Area of research
Surgery · Oncology
Research interest
Research interests include Medicine, Pathology, Hepatocellular carcinoma, Intrahepatic Cholangiocarcinoma, Cadherin, and Biology.
Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999-2019
PARP-1 selectively impairs <i>KRAS</i> -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma
N‐cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas
Deep Learning–Enabled Diagnosis of Liver Adenocarcinoma
Benign lesions of the mediastinum
Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome
Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors
N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas
Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma
Influence of Lymphangio (L), Vascular (V), and Perineural (Pn) Invasion on Recurrence and Survival of Resected Intrahepatic Cholangiocarcinoma
Liver Resection for Intrahepatic Cholangiocarcinoma—Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period
SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report
Cis-E:N-Cadherin-Heterodimere als Charakteristikum von Tumoren des hepatopankreatobiliären Systems
Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer